Matricaria aurea
Matricaria aurea · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Matricaria aurea is a botanical species whose therapeutic potential is primarily concentrated within its vibrant flower. Research focusing on its crude, hydro-alcoholic, and polar hydroethanolic extracts has revealed a diverse profile of bioactive chemicals, including apigenin, luteolin, and various coumarin derivatives. These compounds contribute to significant pharmacological activities, most notably antibacterial, anticancer, and antidiabetic properties. Specifically, the plant shows promise in managing medical conditions such as dyslipidemia, Type 2 Diabetes Mellitus, and infections caused by Streptococcus pyogenes. Consequently, this plant serves as a vital subject for studying natural alternatives in modern medicine.
- Synonyms
- Cenocline Aurea · Chamaemelum Aureum · 7 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Flower
Classification
Common Names
Matricaria aurea is a botanical species widely recognized by several descriptive names. In English-speaking regions, it is most commonly referred to as Golden Chamomile. This name highlights its distinct aesthetic qualities and botanical lineage. In Germany, the plant is known by the traditional common name Gold-Kamille. Whether called by its English or German title, the plant remains a beloved member of its genus.
Sources: Catalogue of Life (COL)
Synonyms
Matricaria aurea is a plant known by several different scientific names across various botanical classifications. It is frequently identified by its synonym Anthemis canescens var. aurea in specific taxonomic contexts. Researchers may also encounter this species documented under the name Cenocline aurea. Furthermore, the plant has been categorized as Chamaemelum aureum and Chamomilla aurea in different studies. Finally, it is recognized in certain literature by the synonym Cotula aurea, reflecting the complex nature of its botanical history.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Matricaria aurea belongs to the vast kingdom Plantae, representing the diverse world of multicellular organisms. Within this kingdom, it is classified under the class Equisetopsida, showcasing its fundamental botanical structure. The plant is further organized into the order Asterales, which connects it to a specific lineage of flowering plants. As a member of the genus Matricaria, it shares close evolutionary ties with several other notable species. Finally, its placement within the family Asteraceae highlights its membership in one of the most prominent and recognizable plant families on Earth.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Matricaria |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Matricaria aurea is widely distributed across the vast landscape of Northern Africa. This resilient plant can be found spanning several key territories throughout the region. Specifically, its presence is well-documented in Algeria and Egypt. It also thrives within the borders of Libya and Morocco. Finally, its natural range extends into the territory of Tunisia, completing its North African footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Matricaria aurea is a delicate herb characterized by its self-supporting growth form. This small plant typically reaches a maximum height of 0.2 meters. However, its stature can vary significantly depending on environmental conditions. In many instances, the plant may remain as short as 0.04 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Matricaria aurea, commonly known as Golden Chamomile, has demonstrated significant medicinal potential through its diverse biological activities. Research indicates that crude extracts of the plant possess potent antibacterial properties, showing particular effectiveness against strains like Streptococcus pyogenes and Staphylococcus aureus. Furthermore, the plant exhibits promising anticancer activity, as evidenced by its ability to induce cell death in various adenocarcinoma cell lines. Beyond these uses, studies have confirmed its antidiabetic effects by showing its capacity to modulate multiple metabolic and inflammatory pathways in type 2 diabetes models. These combined findings highlight the importance of Matricaria aurea as a valuable subject for further pharmaceutical exploration.
Compounds
Matricaria aurea, commonly known as golden chamomile, serves as a rich source of diverse bioactive chemical constituents. Through detailed LC-MS/MS analysis, researchers have identified a wide array of compounds within its hydroethanolic extract. Notably, the plant contains the popular chamomile flavonoids apigenin and luteolin. These specific flavonoids are part of a larger group of phenolic acids and coumarin derivatives present in the herb. The presence of these compounds contributes to the plant's ability to modulate multiple biological targets and pathways.
Conditions
Matricaria aurea demonstrates significant therapeutic potential by improving ALT and AST levels in models of type 2 diabetes. This plant also acts as an effective agent for treating various inflammatory conditions, specifically through the inhibition of matrix-metalloproteinases. Its antimicrobial properties are further highlighted by its ability to treat infections caused by S. aureus. Additionally, the extract exhibits a notable bacteriostatic effect against S. saprophyticus. Collectively, these findings underscore the diverse medicinal efficacy of the plant across metabolic, inflammatory, and bacterial targets.
Preparations
Matricaria aurea is prepared as a crude extract to evaluate its significant antibacterial and anticancer activities against various pathogenic microbes and cancer cell lines. In comparative studies involving anti-inflammatory agents, the plant is also prepared as hydro-alcoholic extracts to assess its therapeutic index and inhibition of matrix-metalloproteinases. Furthermore, investigations into type 2 diabetes mellitus utilize Matricaria aurea prepared as a polar hydroethanolic extract to demonstrate remarkable antidiabetic effects. This specific polar hydroethanolic preparation has been shown to improve insulin resistance and dyslipidemia through the modulation of multiple metabolic pathways. Across these different studies, the various preparation methods of Matricaria aurea allow for the exploration of its diverse medicinal potential.
Parts used
Matricaria aurea offers significant medicinal potential through the bioactive properties found within its crude flower extracts. Recent studies have focused on evaluating these flowers to determine their effectiveness against various infectious diseases and cancer cell lines. Research indicates that the plant possesses notable antibacterial activity, particularly against strains like Streptococcus pyogenes. Furthermore, the extract has demonstrated promising anticancer capabilities by inducing cell death in several adenocarcinoma lines. These findings highlight the importance of the flower as a primary source for discovering new therapeutic components.